BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 18191077)

  • 21. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
    Park SY; Choi YH; Lee W
    J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats.
    Choi SH; Zhao ZS; Lee YJ; Kim SK; Kim DJ; Ahn CW; Lim SK; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2007 Jul; 23(5):411-8. PubMed ID: 17538941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids.
    Bajotto G; Murakami T; Nagasaki M; Qin B; Matsuo Y; Maeda K; Ohashi M; Oshida Y; Sato Y; Shimomura Y
    Metabolism; 2006 Mar; 55(3):317-23. PubMed ID: 16483874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation.
    Kuriyama H; Yamashita S; Shimomura I; Funahashi T; Ishigami M; Aragane K; Miyaoka K; Nakamura T; Takemura K; Man Z; Toide K; Nakayama N; Fukuda Y; Lin MC; Wetterau JR; Matsuzawa Y
    Hepatology; 1998 Feb; 27(2):557-62. PubMed ID: 9462657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats.
    Harada N; Ninomiya C; Osako Y; Morishima M; Mawatari K; Takahashi A; Nakaya Y
    Obes Res; 2004 Jul; 12(7):1077-84. PubMed ID: 15292471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus.
    Bajotto G; Murakami T; Nagasaki M; Tamura T; Tamura N; Harris RA; Shimomura Y; Sato Y
    Life Sci; 2004 Sep; 75(17):2117-30. PubMed ID: 15312755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Mori Y; Nakagiri H; Kondo H; Murase T; Tokimitsu I; Tajima N
    Nutrition; 2005 Sep; 21(9):933-9. PubMed ID: 16023327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liuweidihuang pills reduces visceral fat deposition in Otsuka Long-Evans Tokushima Fatty rats].
    Xue YM; Luo R; Zhu B; Zhang Y; Pan YH; Li CZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1446-8. PubMed ID: 17062348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic dissection of "OLETF," a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF x BN) x OLETF.
    Watanabe TK; Okuno S; Oga K; Mizoguchi-Miyakita A; Tsuji A; Yamasaki Y; Hishigaki H; Kanemoto N; Takagi T; Takahashi E; Irie Y; Nakamura Y; Tanigami A
    Genomics; 1999 Jun; 58(3):233-9. PubMed ID: 10373320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between structural and functional changes of islets, and abnormal metabolism of glucose and lipids in OLETF rats with impaired glucose tolerance].
    Liu Y; Xu Z; Zhang J
    Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):175-7. PubMed ID: 11798752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
    Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
    Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakagawa T; Goto H; Hussein G; Hikiami H; Shibahara N; Shimada Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):40-7. PubMed ID: 18242756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
    Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
    Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
    Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
    J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N; Qi Y; Patel HR; Ahima RS
    J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.
    Hossain A; Yamaguchi F; Hirose K; Matsunaga T; Sui L; Hirata Y; Noguchi C; Katagi A; Kamitori K; Dong Y; Tsukamoto I; Tokuda M
    Drug Des Devel Ther; 2015; 9():525-35. PubMed ID: 25632221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model.
    Shiba Y; Yamasaki Y; Kubota M; Matsuhisa M; Tomita T; Nakahara I; Morishima T; Kawamori R; Hori M
    Metabolism; 1998 Aug; 47(8):908-14. PubMed ID: 9711984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.